About this trial
This study aims to investigate whether lip reading rehabilitation improves viseme recognition in individuals with hearing impairments who use hearing aids.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patient aged 18 or older
Affiliated with a social security system
Moderate to severe bilateral post-lingual hearing loss, fitted with hearing aids for more than 6 months
Wearing hearing aids for a minimum of 8 hours/day on average over the past month
Disqualifiers
Patient who has already undergone speech therapy rehabilitation as part of their hearing loss treatment
Diagnosis of neurodegenerative disease or history of brain injury (traumatic brain injury, stroke, tumor, meningitis, etc.)
Uncorrected vision or visual impairment affecting lip reading (e.g. AMD, glaucoma, unoperated cataract, etc.)
Presence of severe tinnitus (score > 56) on the Tinnitus Handicap Inventory (THI) questionnaire
Trial population
The study population consists of hearing-impaired individuals with hearing aids
Trial design
Case-control
Prospective
Treatments tested in this trial
Speechreading training
Other interventionThe patient will undergo 16 lip reading training sessions. By developing functional lip reading skills, they will be able to fill in the gaps in auditory information they miss, especially in loud or noisy settings
Treatment groups
Trial outcomes
Primary outcomes
Repetition score, in words (with and without labial doppelganger) of Lafon's cochlear lists presented on video support in visual-only modality
Repetition score, in visemes (with and without labial doppelganger) of Lafon's cochlear lists presented on video support in visual-only modality
Secondary outcomes
Repetition score of 10 non-words on recorded support with a Signal-to-Noise Ratio of 10
Repetition score of sentences on video support in audiovisual modality
Identification score of two sequences of musical notes
Impact of speech therapy rehabilitation on quality of life
AVS from 0 to 10
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Institut Pasteur
Lead sponsor
IHU reConnect
Collaborator